Table 2.
Study on the in vitro activity of flavonoids.
Compound | In Vitro Models | Conc. | Effects | Mechanism of Action | References |
---|---|---|---|---|---|
Baicalin | HepG2 cells | 16 μM | Pneumonia | Inhibits NLRP3 inflammatory vesicles | [128] |
Rat IEC-6 cells | 10.0 μg/mL | Inflammatory bowel disease | Inhibits IL-6 and TNF-α inflammatory factor levels | [129] | |
KOPN-8, RCH-ACV, SEM, RS4-11, NALM-6 | 10 mg/mL | Acute B-lymphoblastic leukemia | Inhibits the glycogen synthase kinase 3β and induces cell cycle arrest by upregulating p27Kip1 | [130] | |
MCF-7 and MDA-MB-231 cells | 30 μM | Breast cancer | Inhibits breast cancer cell proliferation and induces G1/S arrest in cells | [131] | |
Vero, BHK-21, and HEK 293T cells | 100 μM | Chikungunya virus | — | [132] | |
Baicalein and baicalin | Vero CCL-81 cells | 20 μM | SARS-CoV-2 | Inhibits SARS-CoV-2 RNA-dependent RNA polymerase activity | [105] |
Baicalein | Vero E6 cell | >2.0 μM | COVID-19 | Inhibits virus replication in vivo and reduces serum levels of IL-1β and TNF-α | [133] |
Vero cell lines | 50 μM | SARS-CoV-2 | Inhibits SARS-CoV-2 replication and its 3C-like protease | [105] | |
HCT116 cells | 50 μM | Colorectal cancer | Induces apoptosis in human colon cancer cells | [134] | |
Silymarin | Vero cells | 749.70 µg/mL | Dengue virus | Binds to the surface protein of the virus to prevent entry into the cell | [70] |
Luteolin | ARPE-19 cells | 50 μM | Age-related macular degeneration | Decreases levels of IL− 8 and IL− 6 | [135] |
MDCK cells and Vero cells | From 3.75 to 240 μM | Influenza A virus | Inhibits the expression of β-COP protein | [136] | |
Enzymatic inhibition assay | 4.6 μM | COVID-19 | Inhibits SARS-CoV-2 RNA-dependent RNA polymerase activity | [25] | |
EGCG | Peripheral blood lymphocytes | 50 μM | HIV | — | [137] |
live SARS-CoV-2 strain | 1 μg/mL | SARS-CoV-2 | Inhibits Nsp15 activity | [111] | |
E. coli | 7.58 μg/ mL | SARS-CoV-2 | Inhibits the activity of 3CLpro | [112] | |
Formononetin | Vero cells | 14.91 μmol/L | Enterovirus 71 | Inhibits EV71-induced COX-2 expression and PGE2 production via MAPKs pathway | [68] |
Biochanin A | A549 cells | 5 μM | H5N1 influenza A viruses | Interferes with AKT, ERK 1/2, and NFκB activation to inhibit viral replication | [65] |
Quercetin | T-REx™-293 cell line | 10 μg/mL | HCV | Inhibits NS3 protease, thereby inhibiting viral replication | [138] |
Naringenin | Huh-7.5 cells | 25 μM | HCV | Reduces production of intracellular viral proteins | [139] |